MX9500885A - Preparacion farmaceutica para administracion oral. - Google Patents

Preparacion farmaceutica para administracion oral.

Info

Publication number
MX9500885A
MX9500885A MX9500885A MX9500885A MX9500885A MX 9500885 A MX9500885 A MX 9500885A MX 9500885 A MX9500885 A MX 9500885A MX 9500885 A MX9500885 A MX 9500885A MX 9500885 A MX9500885 A MX 9500885A
Authority
MX
Mexico
Prior art keywords
active ingredient
oral administration
pharmaceutical preparation
press
film
Prior art date
Application number
MX9500885A
Other languages
English (en)
Inventor
Yoshiyuki Hirakawa
Hiroyuki Yoshino
Katsuji Uemura
Eiji Fukui
Tami Hanamori-Nee-Tami Komoda
Original Assignee
Tanabe Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co filed Critical Tanabe Seiyaku Co
Publication of MX9500885A publication Critical patent/MX9500885A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Una preparacion farmacéutica para administracion oral que comprende: a) un nucleo que contiene un ingrediente activo medicinal; b) una capa revestida mediante prensado que comprende un polímero soluble en agua independientemente del pH, dicha capa estando provista alrededor del nucleo y c) una película que comprende un polímero entérico, dicha película estando provista alrededor de la capa revestida mediante prensado. En la preparacion farmacéutica de la presente invencion, el ingrediente activo medicinal no se libera mientras permanece en el estomago y, después sigue su curso desde el estomago, hasta llegar a un sitio objetivo en el intestino, y posteriormente es liberado rápidamente, por lo que el ingrediente activo intestinal es eficientemente surtido al sitio objetivo en el tracto intestinal.
MX9500885A 1994-02-10 1995-02-09 Preparacion farmaceutica para administracion oral. MX9500885A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6016028A JPH07223970A (ja) 1994-02-10 1994-02-10 消化管内適所放出製剤

Publications (1)

Publication Number Publication Date
MX9500885A true MX9500885A (es) 1997-05-31

Family

ID=11905121

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9500885A MX9500885A (es) 1994-02-10 1995-02-09 Preparacion farmaceutica para administracion oral.

Country Status (7)

Country Link
US (1) US5614220A (es)
EP (1) EP0671167A1 (es)
JP (1) JPH07223970A (es)
KR (1) KR950031048A (es)
CN (1) CN1116926A (es)
CA (1) CA2142142A1 (es)
MX (1) MX9500885A (es)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5580578A (en) * 1992-01-27 1996-12-03 Euro-Celtique, S.A. Controlled release formulations coated with aqueous dispersions of acrylic polymers
US7070806B2 (en) * 1992-01-27 2006-07-04 Purdue Pharma Lp Controlled release formulations coated with aqueous dispersions of acrylic polymers
US5567441A (en) * 1995-03-24 1996-10-22 Andrx Pharmaceuticals Inc. Diltiazem controlled release formulation
US5830503A (en) * 1996-06-21 1998-11-03 Andrx Pharmaceuticals, Inc. Enteric coated diltiazem once-a-day formulation
US5851579A (en) * 1996-10-28 1998-12-22 Eastman Chemical Company Aqueous enteric coating compositions
WO1998026767A2 (en) * 1996-12-17 1998-06-25 Poli Industria Chimica S.P.A. Site-specific controlled release dosage formulation for mesalamine
US5891474A (en) 1997-01-29 1999-04-06 Poli Industria Chimica, S.P.A. Time-specific controlled release dosage formulations and method of preparing same
JP2000128779A (ja) * 1998-10-20 2000-05-09 Mitsui Chemicals Inc 薬物放出制御型製剤
WO2000044353A1 (de) 1999-01-29 2000-08-03 Losan Pharma Gmbh Pharmazeutische zusammensetzungen
SE9901387D0 (sv) * 1999-04-19 1999-04-19 Astra Ab New pharmaceutical foromaulations
US6632451B2 (en) 1999-06-04 2003-10-14 Dexcel Pharma Technologies Ltd. Delayed total release two pulse gastrointestinal drug delivery system
IN190974B (es) * 1999-09-10 2003-09-06 Ranbaxy Lab Ltd
US6635277B2 (en) 2000-04-12 2003-10-21 Wockhardt Limited Composition for pulsatile delivery of diltiazem and process of manufacture
DE60116758T2 (de) 2000-05-18 2006-11-02 Therics, Inc. Einkapselung eines toxischen kerns in einen nicht-toxischen bereich in einer oralen darreichungsform
CA2412776C (en) 2000-06-16 2011-03-15 Mitsubishi Pharma Corporation Compositions controlling release ph range and/or speed
US7223421B2 (en) * 2000-06-30 2007-05-29 Mcneil-Ppc, Inc. Teste masked pharmaceutical particles
US6500457B1 (en) 2000-08-14 2002-12-31 Peirce Management, Llc Oral pharmaceutical dosage forms for pulsatile delivery of an antiarrhythmic agent
SE0003766D0 (sv) * 2000-10-18 2000-10-18 Astrazeneca Ab Novel formulation
US20020119196A1 (en) * 2000-12-21 2002-08-29 Narendra Parikh Texture masked particles containing an active ingredient
US6569292B2 (en) 2001-04-04 2003-05-27 Texas Christian University Method and device for forming a calcium phosphate film on a substrate
WO2004087109A1 (ja) * 2003-03-27 2004-10-14 Hisamitsu Pharmaceutical Co., Inc. 大腸送達性経口医薬製剤、大腸癌治療用経口医薬製剤および大腸炎治療用経口医薬製剤
US20060079578A1 (en) * 2003-06-23 2006-04-13 Julie Laurin Pharmaceutical formulations of amyloid inhibiting compounds
US20050142191A1 (en) * 2003-06-23 2005-06-30 Neurochem (International) Limited Pharmaceutical formulations of amyloid inhibiting compounds
GB0320522D0 (en) * 2003-09-02 2003-10-01 Glaxo Group Ltd Formulation
US20060024368A1 (en) * 2004-07-30 2006-02-02 Reza Fassihi Compressed composite delivery system for release-rate modulation of bioactives
AR052225A1 (es) * 2004-11-04 2007-03-07 Astrazeneca Ab Formulaciones de tabletas de liberacion modificada par inhibidores de la bomba de protones
AR051654A1 (es) * 2004-11-04 2007-01-31 Astrazeneca Ab Nuevas formulaciones de pellets de liberacion modificada para inhibidores de la bomba de protones
WO2007069073A2 (en) * 2005-04-12 2007-06-21 Neurochem (International) Limited Pharmaceutical formulations of amyloid inhibiting compounds
US20090036414A1 (en) * 2007-08-02 2009-02-05 Mutual Pharmaceutical Company, Inc. Mesalamine Formulations
GB201003734D0 (en) 2010-03-05 2010-04-21 Univ Strathclyde Delayed prolonged drug delivery
GB201003731D0 (en) 2010-03-05 2010-04-21 Univ Strathclyde Immediate/delayed drug delivery
GB201003766D0 (en) * 2010-03-05 2010-04-21 Univ Strathclyde Pulsatile drug release
WO2012147100A1 (en) * 2011-04-25 2012-11-01 Hetero Research Foundation Extended release compositions of quetiapine
GB201420306D0 (en) * 2014-11-14 2014-12-31 Bio Images Drug Delivery Ltd Compositions
TR201722039A2 (tr) * 2017-12-27 2019-07-22 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Mesalazi̇ni̇n kati oral farmasöti̇k kompozi̇syonlari

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2189699A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated acid-labile medicaments
US5068110A (en) * 1987-09-29 1991-11-26 Warner-Lambert Company Stabilization of enteric coated dosage form
IT1230576B (it) * 1988-10-20 1991-10-28 Angeli Inst Spa Formulazioni farmaceutiche per via orale a liberazione selettiva nel colon
US5202128A (en) * 1989-01-06 1993-04-13 F. H. Faulding & Co. Limited Sustained release pharmaceutical composition
ES2106818T3 (es) * 1991-10-30 1997-11-16 Glaxo Group Ltd Composicion multicapa que contiene antagonistas de histamina o secotina.
US5167964A (en) * 1992-02-14 1992-12-01 Warner-Lambert Company Semi-enteric drug delivery systems and methods for preparing same

Also Published As

Publication number Publication date
CA2142142A1 (en) 1995-08-11
KR950031048A (ko) 1995-12-18
EP0671167A1 (en) 1995-09-13
US5614220A (en) 1997-03-25
CN1116926A (zh) 1996-02-21
JPH07223970A (ja) 1995-08-22

Similar Documents

Publication Publication Date Title
MX9500885A (es) Preparacion farmaceutica para administracion oral.
CA2144094A1 (en) Pharmaceutical preparation controlled to release medicinal active ingredient at targeted site in intestinal tract
ID17428A (id) Sediaan farmasi da;lam bentuk kapsult bersalut yang dapat dilepas pada bagian bawah saluran pencernaan
ATE205705T1 (de) Arzneimittel zum wirkstoff - targetting in den dickdarm
HK1028187A1 (en) Film-coated tablet for improved upper gastrointestinal tract safety.
PT825858E (pt) Capsulas de libertacao dependente do tempo contendo acidos poliinsaturados omega-3 para o tratamento da doenca inflamatoria do intestino
GEP20033014B (en) Enteric Coated Pharmaceutical Composition and Method of Manufacturing
ATE261301T1 (de) Arzneizubereitungen enthaltend nicht-steroidale entzündungshemmende arzneimittel
IS1694B (is) Lyfjablanda til að gefa dýrum um munn sem inniheldur prótonupumpublokkara
CA2065773A1 (en) Gastroresistant pharmaceutical formulations for oral administration containing bile acids
ATE247457T1 (de) Stabile arzneiform mit benzimidazolderivaten als wirkstoff zur oralen verabreichung und verfahren zu ihrer herstellung
RU2227033C2 (ru) Тауролидин и/или таурултам при лечении инфекционной язвенной болезни или инфекционного гастрита
SE8306367L (sv) Antidiuretiskt verkande farmaceutiskt preparat
JP2001514218A5 (es)
TH22304A (th) สารเตรียมทางเภสัชกรรมแบบหลายหน่วยที่มีสารยัยยั้งปั๊มโปรตอน
TH31107B (th) ยาเม็ดเคลือบฟิล์มสำหรับความปลอดภัยที่ดีขึ้นสำหรับทางเดินกระเพาะลำไส้ตอนบน
IT1269412B (it) Apparecchio distributore di farmaci
TH4687EX (th) สูตรผสมทางเภสัชของสารที่เปลี่ยนแปลงได้ด้วยกรดสำหรับการใช้ทางปาก